Search results Search for: Search Refine your results by duration: Any Under 5 mins Under 20 mins Over 20 mins Sort by: Relevance Views Date Contromisure per i difensori della cybersecurity Paolo Melchiori - Senior Solutions Engineer In questo webinar l’esperto di sicurezza di SonicWall presenta il Rapporto SonicWall 2023 sul Cybercrime e spiega quanto sia importante implementare c... 2 days ago | 58 mins The Importance of Accurate Chemical Characterization of Medical Devices... Ron Brown, Toxicologist at Risk Science Consortium and Dries Cardoen, PhD, Sr. E&L Expert – Team leader at Nelson Labs Full title: The Importance of Accurate Chemical Characterization of Medical Devices Extractables Chemical characterization of medical devices, involv... 4 months ago | 134 mins ICH Q3E Impurity Guidelines: Assessment and Control of Extractractables... Jason Creasey at Maven E&L Ltd, and Philippe Verlinde at Nelson Labs Full title: ICH Q3E Impurity Guidelines: Assessment and Control of Extractractables and Leachables for Pharmaceuticals and Biologics. 6 months ago | 116 mins Reinventing the Web: Web3, Blockchain, and NFTs Brian Piper, Director of Content Strategy and Assessment, University of Rochester What is this Web3 that everyone is talking about? What is crypto and NFTs, and how will this affect you and your business? Learn the basics of these n... 3 months ago | 58 mins Risk Assessment of Extractables and Leachables... Presented by Dr Clemens Günther, Senior Expert Nonclinical Safety, Director at Bayer AG, R&D Pharmaceuticals Full title: Risk Assessment of Extractables and Leachables in Different Phases of Development. As the knowledge on the manufacturing process evolves ... 2 years ago | 127 mins Extractable Data Mining: Common Extractables From Polymeric Manufacturing Materi Ping Wang, Director at Johnson & Johnson and Donald DeCou, E&L Technology Manager at West Pharmaceutical Services Full Title: Extractable Data Mining: Common Extractables From Polymeric Manufacturing Materials Used in Biologics Production Presented by Ping Wang, D... 3 years ago | 79 mins An impurity detected in a stability study... Petra Booij, Investigator bij GlaxoSmithKline and Ward D’Autry, PhD Study Director at Nelson Labs Europe Full Title: An impurity detected in a stability study: Did we miss anything in our E&L risk assessment? Extractable and leachable (E&L) testing are r... 1 year ago | 90 mins The Reality of Vendor Risk Assessments Jon Ehret, VP of Strategy & Risk, RiskRecon & Tony UcedaVélez, CEO, VerSprite For years many cybersecurity professionals have been trying to understand how to measure cyber risk. Why is this important? If you have a solid unders... 2 years ago | 55 mins Current Progress in Approaches for The Safety Assessment of E&L Kim Li, PhD, DABT, MPH, Amgen Inc.& Erica J. Tullo, Technology Manager, E&L – Analytical Labs, West Pharmaceutical Service Title: Current Progress in Approaches for The Safety Assessment of E&L Presenter: Kim Li, PhD, DABT, MPH, Amgen Inc Summary: This Webinar will review ... 5 years ago | 75 mins Cyber Due Diligence: Pre-Transaction Assessment Can Uncover Costly Risks Timothy P. Ryan, Kroll How can you ensure that an investment target isn’t one keystroke away from a major cyber incident or data breach? How can you be sure that an attacker... 8 years ago | 38 mins Load more
